These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16957494)

  • 41. A review of the acute subjective effects of MDMA/ecstasy.
    Baylen CA; Rosenberg H
    Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Problem solving ability in patients with mild cognitive impairment.
    Beversdorf DQ; Ferguson JL; Hillier A; Sharma UK; Nagaraja HN; Bornstein RA; Scharre DW
    Cogn Behav Neurol; 2007 Mar; 20(1):44-7. PubMed ID: 17356344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing the functional significance of ecstasy-related memory deficits using a virtual paradigm.
    Montgomery C; Hatton NP; Fisk JE; Ogden RS; Jansari A
    Hum Psychopharmacol; 2010; 25(4):318-25. PubMed ID: 20521322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users.
    Back-Madruga C; Boone KB; Chang L; Grob CS; Lee A; Nations H; Poland RE
    Clin Neuropsychol; 2003 Nov; 17(4):446-59. PubMed ID: 15168910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implicit cognition is impaired and dissociable in a head-injured group with executive deficits.
    Barker LA; Andrade J; Romanowski CA; Morton N; Wasti A
    Neuropsychologia; 2006; 44(8):1413-24. PubMed ID: 16436286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.
    Parrott AC; Lasky J
    Psychopharmacology (Berl); 1998 Oct; 139(3):261-8. PubMed ID: 9784083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is moderate substance use associated with altered executive functioning in a population-based sample of young adults?
    Piechatzek M; Indlekofer F; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    Hum Psychopharmacol; 2009 Dec; 24(8):650-65. PubMed ID: 19946940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. No evidence of decrease in cognitive function in users of low-dose Ecstasy.
    Krebs TS; Johansen PØ
    Arch Gen Psychiatry; 2008 Feb; 65(2):236; author reply 236-7. PubMed ID: 18250261
    [No Abstract]   [Full Text] [Related]  

  • 49. The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.
    Sumnall HR; Cole JC; Jerome L
    J Psychopharmacol; 2006 Sep; 20(5):670-82. PubMed ID: 16401654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia.
    Malhi GS; Ivanovski B; Hadzi-Pavlovic D; Mitchell PB; Vieta E; Sachdev P
    Bipolar Disord; 2007; 9(1-2):114-25. PubMed ID: 17391355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Psychiatric and cognitive long-term effects of ecstasy].
    Høiseth G; Løvåsdal Ø; Titze TK; Bramness JG; Bachs L
    Tidsskr Nor Laegeforen; 2006 Feb; 126(5):596-8. PubMed ID: 16505868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.
    Schilt T; de Win MM; Jager G; Koeter MW; Ramsey NF; Schmand B; van den Brink W
    Psychol Med; 2008 Sep; 38(9):1309-17. PubMed ID: 17988417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
    Huxster JK; Pirona A; Morgan MJ
    J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mental disorders in current and former heavy ecstasy (MDMA) users.
    Thomasius R; Petersen KU; Zapletalova P; Wartberg L; Zeichner D; Schmoldt A
    Addiction; 2005 Sep; 100(9):1310-9. PubMed ID: 16128720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrophysiological indices of altered working memory processes in long-term ecstasy users.
    Nulsen C; Fox A; Hammond G
    Hum Psychopharmacol; 2011 Oct; 26(7):488-97. PubMed ID: 21953632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is there cognitive impairment in clinically 'healthy' abstinent alcohol dependence?
    Davies SJ; Pandit SA; Feeney A; Stevenson BJ; Kerwin RW; Nutt DJ; Marshall EJ; Boddington S; Lingford-Hughes A
    Alcohol Alcohol; 2005; 40(6):498-503. PubMed ID: 16186142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Raven's Coloured Progressive Matrices as a measure of cognitive functioning in Cerebral Palsy.
    Pueyo R; Junqué C; Vendrell P; Narberhaus A; Segarra D
    J Intellect Disabil Res; 2008 May; 52(Pt 5):437-45. PubMed ID: 18312310
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs.
    Halpern JH; Pope HG; Sherwood AR; Barry S; Hudson JI; Yurgelun-Todd D
    Drug Alcohol Depend; 2004 Aug; 75(2):135-47. PubMed ID: 15276218
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G; Elston J; Garside R; Roome C; Taylor R; Younger P; Zawada A; Somerville M
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of Ecstasy on memory is moderated by a functional polymorphism in the cathechol-O-methyltransferase (COMT) gene.
    Schilt T; Koeter MW; de Win MM; Zinkstok JR; van Amelsvoort TA; Schmand B; den Brink Wv
    Eur Neuropsychopharmacol; 2009 Feb; 19(2):116-24. PubMed ID: 19042106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.